JP3942400007
JP3942400007
ASTELLAS PHARMA
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 |
|---|---|---|
Market & Enterprise Value | ||
Market Cap | 4.03T EUR | 3.8T EUR |
Enterprise Value | 4.38T EUR | 3.8T EUR |
Valuation Multiples | ||
Trailing P/E | 11.07x | -- |
Forward P/E | 29.66x | -- |
Price to Sales | 1.77x | -- |
Price to Book | 2.07x | -- |
EV/Revenue | 1.92x | -- |
EV/EBITDA | 6.54x | -- |
Price to FCF (P/FCF) | 10.51x | -- |
EV/FCF | 11.41x | -- |
FCF Yield | 9.52% | -- |